| Chlorogenic acid ameliorates experimental colitis in mice by suppressing signaling pathways involved in inflammatory response and apoptosis I Vukelić, D Detel, LB Pučar, I Potočnjak, S Buljević, R Domitrović Food and chemical toxicology 121, 140-150, 2018 | 80 | 2018 |
| Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS‐induced model of colitis in mice L Baticic, D Detel, N Kucic, S Buljevic, EP Pugel, J Varljen Journal of cellular biochemistry 112 (11), 3322-3333, 2011 | 47 | 2011 |
| Luteolin ameliorates experimental colitis in mice through ERK-mediated suppression of inflammation, apoptosis and autophagy I Vukelić, D Detel, L Batičić, I Potočnjak, R Domitrović Food and chemical toxicology 145, 111680, 2020 | 40 | 2020 |
| Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease D Detel, M Peršic, J Varljen Journal of pediatric gastroenterology and nutrition 45 (1), 65-70, 2007 | 39 | 2007 |
| Involvement of DPP IV/CD26 in cutaneous wound healing process in mice L Baticic Pucar, E Pernjak Pugel, D Detel, J Varljen Wound repair and regeneration 25 (1), 25-40, 2017 | 31 | 2017 |
| Clinical relevance of the serum dipeptidyl peptidase IV (DPP IV/CD26) activity in adult patients with Crohn’s disease and ulcerative colitis J Varljen, B Mijandrušić Sinčić, L Batičić, N Varljen, D Detel, A Lekić Croatica chemica acta 78 (3), 427-432, 2005 | 28 | 2005 |
| The influence of age on intestinal dipeptidyl peptidase IV (DPP IV/CD26), disaccharidases, and alkaline phosphatase enzyme activity in C57BL/6 mice D Detel, L Baticic, J Varljen Experimental aging research 34 (1), 49-62, 2007 | 27 | 2007 |
| Serum activities of adenosine deaminase, dipeptidyl peptidase IV and prolyl endopeptidase in patients with fibromyalgia: diagnostic implications O Čulić, MD Cordero, T Žanić-Grubišić, A Somborac-Bačura, LB Pučar, ... Clinical rheumatology 35, 2565-2571, 2016 | 26 | 2016 |
| Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients S Buljevic, D Detel, LB Pucar, R Mihelic, T Madarevic, B Sestan, J Varljen Rheumatology international 33, 2867-2874, 2013 | 25 | 2013 |
| Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV D Detel, EP Pugel, LB Pucar, S Buljevic, J Varljen Experimental physiology 97 (4), 486-496, 2012 | 24 | 2012 |
| Decreased soluble dipeptidyl peptidase IV activity as a potential serum biomarker for COPD A Somborac-Bačura, S Buljević, L Rumora, O Čulić, D Detel, D Pancirov, ... Clinical biochemistry 45 (15), 1245-1250, 2012 | 23 | 2012 |
| Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution D Detel, S Buljevic, LB Pucar, N Kucic, EP Pugel, J Varljen Journal of physiology and biochemistry 72, 405-419, 2016 | 15 | 2016 |
| Profiling Colorectal Cancer in the Landscape Personalized Testing—Advantages of Liquid Biopsy D Verbanac, A Čeri, I Hlapčić, M Shakibaei, A Brockmueller, B Krušlin, ... International journal of molecular sciences 22 (9), 4327, 2021 | 8 | 2021 |
| The effect of CD26‐deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease S Buljevic, D Detel, EP Pugel, J Varljen Journal of cellular biochemistry 119 (8), 6743-6755, 2018 | 8 | 2018 |
| Age dependent activity of brush-border enzymes in BALB/c mice J Varljen, D Detel, L Batičić, V Eraković, N Štrbo, M Ćuk, Č Milin Croatica chemica acta 78 (3), 379-384, 2005 | 5 | 2005 |
| Proces cijeljenja rane i dipeptidil-peptidaza IV L Batičić Pučar, A Grčić, E Pernjak Pugel, D Detel, J Varljen Medicina Fluminensis: Medicina Fluminensis 53 (1), 4-15, 2017 | 4 | 2017 |
| Dipeptidil-peptidaza IV (DPP IV/CD26) i upalne bolesti crijeva L Batičić Pučar, D Detel, J Varljen Arhiv za higijenu rada i toksikologiju 63 (1), 75-99, 2012 | 4 | 2012 |
| CD26 deficiency controls macrophage polarization markers and signal transducers during colitis development and resolution I Vukelic, S Buljevic, L Baticic, K Barisic, B Franovic, D Detel International journal of molecular sciences 23 (10), 5506, 2022 | 3 | 2022 |
| Dyslipidemia: Current perspectives and implications for clinical practice SK Majanović, OC Peloza, D Detel, GK Jovanović, M Bakula, D Rahelic, ... Management of Dyslipidemia, 3, 2021 | 3 | 2021 |
| Obesogens–new global health problem? M Ćurić, SK Majanović, D Detel, A Ružić, D Štimac Periodicum biologorum 123 (3-4), 49-53, 2021 | 2 | 2021 |
